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IP01.493I N-ACETYL-CYSTEINE TREATMENT INHIBITS 
DEPLETION OF BRAIN GLUTATHIONE LEVELS IN 
RATS: IMPLICATIONS FOR SCHIZOPHRENIA 
0. Dean1 , M. van den Buuse1 , D. Copolov1 , M. Berk2 , A. Bush1 . 1 Mental Health 
Research Institute, Australia; 2 University of Melbourne, Australia 
Statement of the Study: Reduced brain levels of glutathione and oxidative 
stress have recently been proposed as contributing factors in Schizophrenia. 
Glutathione is a free radical scavenger and its depletion, associated with the 
oxidative stress effects of altered dopamine release, may be implicated in the 
symptomatic process of the illness. Currently, a clinical trial is underway in which 
treatment with the antioxidant N-acetyl cysteine (NAC) is added to standard 
neuroleptic treatment. The aim of the present study was to investigate, in rats, 
possible biochemical mechanisms involved in the effects of this treatment. 
Methods: Adult male Sprague-Dawley rats (ave. weight 420g) were treated 
with 2-Cyclohexene-1-one [CHX, 75 mg!kg, intraperitoneally (i.p.)]. NAC 
( 1000 mg!kg, i. p.) was administered ninety minutes proceeding CHX treatment, 
and D-amphetamine sulphate (amphetamine, 2.5 mg!kg, i.p.) was injected 30 
minutes later to induce dopaminergic hyperactivity. In all cases, control rats 
received saline injections (i.p.) in equal volumes to the treated rat. One hour 
following amphetamine treatment, striatal and frontal cortex samples were 
obtained for biochemical analysis. 
Summary of Results: Results show that CHX induced a significant depletion 
of glutathione levels in both striatum and cortex of CHX-alone treated rats, but 
not in CHX-NAC treated rats. This effect occurred in both amphetamine-treated 
and saline-treated rats, although the effect appeared greater in the absence of 
amphetamine treatment. 
Conclusion: These results demonstrate NAC treatment can restore depleted 
levels of cerebral glutathione. This predicts beneficial effects of this treatment 
in clinical conditions where brain glutathione levels are depleted, such as in 
schizophrenia. 
